Is a single lipoprotein (a) measurement once in a lifetime sufficient? The results from the STAR-Lp(a) study.

29 August 2025 (10:15 - 11:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Professor Piotr Jankowski

The Medical Centre of Postgraduate Education, Warsaw (Poland)

6 More presentations in this session

Presentation thumbnail

Association of atherogenic index of plasma trajectory with the incidence of cardiovascular disease over a 12-year follow-up: findings from the ELSA cohort study

Doctor X. Li (Kunming, CN)

Abstract Slides Video

Presentation thumbnail

Small dense low-density lipoprotein cholesterol potentiates the risk of Lp(a) for long-term secondary prevention in patients with stable coronary artery disease

Professor S. Koba (Tokyo, JP)

Abstract Slides Video

Presentation thumbnail

Coronary artery disease and the bad dual: homocysteine and lipoprotein (a)

Doctor F. Sousa (Funchal, PT)

Abstract Slides Video

Presentation thumbnail

Prognostic value of cardiac myosin binding protein C in the general population: The Akershus Cardiac Examination 1950 Study

Doctor M. Lyngbakken (Nordbyhagen, NO)

Abstract Slides Video

Presentation thumbnail

Clonal Hematopoiesis and Cardiovascular Outcomes in the Elderly

Mr D. Ezzat (BE)

Abstract Slides Video

Access the full session

Session thumbnail

Risk factors (1)

The Event

Event poster

ESC Congress 2025

29 August 2025 10:15 CET

You may be interested in

Congress Presentation

Lipoprotein(a) variability: challenging the one-time measurement paradigm in cardiovascular risk assessment

Congress Presentation

The determinants of lack of atherosclerosis progression in adult patients with elevated lipoprotein(a). The results from the STAR-Lp(a) study.

Congress Presentation

Is lipoprotein(a) a stable measurement over time?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources